Coppa A, Mincione G, Mammarella S, Ranieri A, Colletta G
Department of Experimental Medicine, University of La Sapienza, Rome, Italy.
Cell Growth Differ. 1995 Mar;6(3):281-90.
Transforming growth factor beta (TGF beta) acts on epithelial thyroid cells, negatively controlling their proliferation and functions. The effects of TGF beta on epithelial rat thyroid cells (FRTL-5) and on two TGF beta-resistant rat thyroid cell clones (FRTL-5H2 and FRTL-R) were investigated. FRTL-5H2 represents a rat thyroid cell clone overexpressing active erbB-2 oncogene, recently obtained after FRTL-5 cell infection with a retrovirus vector carrying the erbB-2 human oncogene (G. Mincione et al., Cancer Res., 53: 5548-5553, 1993). FRTL-R is a FRTL-5 subclone spontaneously isolated after long term in culture. FRTL-5H2 and FRTL-R cell clones were stimulated by TGF beta at the same concentration of 5 ng/ml that induced 70% inhibition of [3H]thymidine incorporation in control FRTL-5 thyroid cells. Nuclear events regulated by TGF beta, such as cyclin and cyclin-dependent kinase gene expression, were then analyzed. In FRTL-5 cells, TGF beta was found to reduce the expression of cdk2 and cyclin A genes; the same treatment did not modify nuclear gene expression in the resistant cell clones. TGF beta is known to reduce iodide uptake in thyroid cells; in both FRTL-5H2 and FRTL-R cells, TGF beta was found to inhibit the thyrotropin-induced iodide uptake. Thus, thyroid cell clones, resistant to the growth-inhibitory activity of TGF beta, were sensitive to TGF beta inhibition of iodide incorporation, suggesting that TGF beta activates divergent signaling pathways in these cells, separately controlling cell proliferation and differentiation parameters. Studies on TGF beta receptors showed similar amounts of TGF beta-binding species on FRTL-5 cells and TGF beta-resistant clones, while 125I-labeled TGF beta cross-linking experiments revealed differences; thus, the TGF beta-resistant cells showed a 40% decrease in the amount of labeled type II TGF beta receptor on the cell surface. However, this different pattern of TGF beta receptors cannot totally account for the shown TGF beta resistance to growth inhibition that might also be due to perturbation in signaling pathways.
转化生长因子β(TGFβ)作用于甲状腺上皮细胞,对其增殖和功能起负向调控作用。本研究调查了TGFβ对大鼠甲状腺上皮细胞(FRTL - 5)以及两种对TGFβ耐药的大鼠甲状腺细胞克隆(FRTL - 5H2和FRTL - R)的影响。FRTL - 5H2是一个过表达活性erbB - 2癌基因的大鼠甲状腺细胞克隆,它是近期用携带erbB - 2人类癌基因的逆转录病毒载体感染FRTL - 5细胞后获得的(G. Mincione等人,《癌症研究》,53: 5548 - 5553,1993)。FRTL - R是长期培养后自发分离得到的FRTL - 5亚克隆。FRTL - 5H2和FRTL - R细胞克隆用浓度为5 ng/ml的TGFβ刺激,该浓度可使对照FRTL - 5甲状腺细胞中[3H]胸腺嘧啶核苷掺入量受到70%的抑制。随后分析了由TGFβ调控的核事件,如细胞周期蛋白和细胞周期蛋白依赖性激酶基因的表达。在FRTL - 5细胞中,发现TGFβ可降低cdk2和细胞周期蛋白A基因的表达;相同处理并未改变耐药细胞克隆中的核基因表达。已知TGFβ可降低甲状腺细胞中的碘摄取;在FRTL - 5H2和FRTL - R细胞中,均发现TGFβ可抑制促甲状腺激素诱导的碘摄取。因此,对TGFβ生长抑制活性耐药的甲状腺细胞克隆对TGFβ抑制碘掺入敏感,这表明TGFβ在这些细胞中激活了不同的信号通路,分别控制细胞增殖和分化参数。对TGFβ受体的研究表明,FRTL - 5细胞和TGFβ耐药克隆上TGFβ结合分子的量相似,而125I标记的TGFβ交联实验揭示了差异;因此,TGFβ耐药细胞表面标记的II型TGFβ受体量减少了40%。然而,TGFβ受体的这种不同模式并不能完全解释所显示的TGFβ对生长抑制的耐药性,这也可能是由于信号通路的紊乱所致。